These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 14067574)

  • 1. [PHARMACOLOGICAL CHARACTERIZATION AND DETECTION OF HALLUCINOGENIC SUBSTANCES. I. HYPERTHERMIC ACTION IN THE RABBIT].
    JACOB J; LAFILLE C
    Arch Int Pharmacodyn Ther; 1963 Oct; 145():528-45. PubMed ID: 14067574
    [No Abstract]   [Full Text] [Related]  

  • 2. [RESEARCH CONCERNING THE PHARMACOLOGIC CHARACTERIZATION AND DIFFERENTIATION OF HALLUCINOGENIC DRUGS (INDOLE DERIVATES AND MESCALINE, NALORPHINE, CENTRAL ANTICHOLINERGIC AGENTS, PHENCYCLIDINE)].
    JACOB J; LAFILLE C; LOISEAU G; ECHINARD-GARIN P; BARTHELEMY C
    Encephale; 1964; 53():520-35. PubMed ID: 14222727
    [No Abstract]   [Full Text] [Related]  

  • 3. THE ANTIDOTAL ACTION OF NALORPHINE IN COMBATTING ALCOHOL INDUCED BRADYPNEA IN THE RABBIT.
    FROMMEL E; VON LEDEBUR ; JOYE E; DUDA M; SEYDOUX J
    Med Exp Int J Exp Med; 1963; 9():38-40. PubMed ID: 14046724
    [No Abstract]   [Full Text] [Related]  

  • 4. [ACTION OF SOME HYPERTHERMIC AND HYPOTHERMIC PHARMACODYNAMIC BASAL METABOLISM OF THE RABBIT. EXPERIMENTAL APPARATUS].
    LEVASSORT C
    J Physiol (Paris); 1964; 56():767-72. PubMed ID: 14268525
    [No Abstract]   [Full Text] [Related]  

  • 5. [PHARMACOLOGICAL PROPERTIES OF SOME NEW TRANQUILIZERS AND ANTIDEPRESSIVE SUBSTANCES].
    METYSOVA J; METYS J; VOTAVA Z
    Arch Int Pharmacodyn Ther; 1963 Aug; 144():481-513. PubMed ID: 14060871
    [No Abstract]   [Full Text] [Related]  

  • 6. SIMULTANEOUS STUDIES OF BLOOD SUGAR, BEHAVIOURAL CHANGES AND EEG ON THE WAKE RABBIT AFTER ADMINISTRATION OF PSILOCYBIN.
    STEINER JE; SULMAN FG
    Arch Int Pharmacodyn Ther; 1963 Oct; 145():301-8. PubMed ID: 14067558
    [No Abstract]   [Full Text] [Related]  

  • 7. [DIFFERENTIATION OF HYPERTHERMIC AGENTS BY COMPARISON OF THEIR ACTION AS A FUNCTION OF DOSES].
    LECHAT P; DELEAU D
    C R Seances Soc Biol Fil; 1964; 158():290-4. PubMed ID: 14188424
    [No Abstract]   [Full Text] [Related]  

  • 8. [COMPARISONS OF POSTGANGLIONAL ENERVATION WITH THE ACTION OF CERTAIN SUBSTANCES ON THE NICTITATING MEMBRANE OF THE CAT].
    SCHMITT H
    Arch Int Pharmacodyn Ther; 1963 Oct; 145():518-27. PubMed ID: 14067573
    [No Abstract]   [Full Text] [Related]  

  • 9. Discriminative stimulus properties of hallucinogens and related designer drugs.
    Glennon RA
    NIDA Res Monogr; 1991; (116):25-44. PubMed ID: 1369672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biochemical, pharmacological and clinical studies with opiates, cannabinoles, stimulants and hallucinogens].
    Matussek N
    Offentl Gesundheitswes; 1971 Sep; 33(9):534-40. PubMed ID: 4258151
    [No Abstract]   [Full Text] [Related]  

  • 11. Some aspects of the comparative pharmacology of morphine.
    Maynert EW
    Fed Proc; 1967; 26(4):1111-4. PubMed ID: 4381930
    [No Abstract]   [Full Text] [Related]  

  • 12. [Old and new investigations on hallucinogenic mushrooms from Mexico, on their action and on the substances which are responsible for their action].
    HEIM R
    Actual Pharmacol (Paris); 1959; 12():171-92. PubMed ID: 14400658
    [No Abstract]   [Full Text] [Related]  

  • 13. [CLASSIFICATION OF THE EFFECTS PRODUCED BY PSYCHOLEPTIC AND HALLUCINOGENIC DRUGS].
    DAVID JM
    Rev Argent Neurol Psiquiatr; 1964; 1():305-8. PubMed ID: 14322260
    [No Abstract]   [Full Text] [Related]  

  • 14. [Interaction of pharmacological and psychodynamismic mechanisms in the effects of hallucinogenic drugs. Hypothesis on the nature and mechanisms of their specific therapeutic action in psychiatry].
    DAVID JM; ALONSO DE DAVID AE
    Sem Med; 1962 Mar; 120():336-42. PubMed ID: 13883754
    [No Abstract]   [Full Text] [Related]  

  • 15. Correlation between potency and UV spectra of hallucinogenic amphetamines.
    Bailey K; Verner D
    J Pharm Sci; 1972 Mar; 61(3):480-1. PubMed ID: 5013397
    [No Abstract]   [Full Text] [Related]  

  • 16. Dimethylacetamide: a hitherto unrecognized hallucinogenic agent.
    WEISS AJ; MANCALL EL; KOLTES JA; WHITE JC; JACKSON LG
    Science; 1962 Apr; 136(3511):151-2. PubMed ID: 14005854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [HALLUCINOGENIC SUBSTANCES. THEIR ROLE IN RESEARCH AND IN CURRENT PSYCHIATRIC THERAPY].
    BENOIT JC
    Sem Hop; 1963 Oct; 39():2184-90. PubMed ID: 14134268
    [No Abstract]   [Full Text] [Related]  

  • 18. The pharmacology of nalorphine (N-allylnormorphine).
    WOODS LA
    Pharmacol Rev; 1956 Jun; 8(2):175-98. PubMed ID: 13335492
    [No Abstract]   [Full Text] [Related]  

  • 19. Human pharmacology and clinical uses of nalorphine (N-allylnormorphine).
    FRASER HF
    Med Clin North Am; 1957 Mar; 41(2):393-403. PubMed ID: 13407226
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of two hallucinogenic agents on human retinal function.
    KRILL AE; WIELAND AM; OSTFELD AM
    Arch Ophthalmol; 1960 Nov; 64():724-33. PubMed ID: 13754343
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.